Chairman, CEO, & Founder, Alexandria Real Estate Equities
Co-Founder and CEO, DNAnexus
VP of Research & Policy, Ewing Marion Kauffman Foundation
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Certain genes in the human body inadvertently protect cancer cells against necessary chemotherapy treatments. Through the identification of small-molecule lead compounds, scientists at Sanford-Burnham have been able to stop these “anti-death” genes from shielding cancer cells, making anti-cancer therapeutics more effective. Sanford-Burnham’s cancer research efforts also have enabled researchers to selectively target drugs to specific blood vessels, using vascular “zip codes.” More information and online registration is here.